Jared Holz, Mizuho, joins ‘Fast Money’ to talk Novo Nordisk shares sliding on latest drug trial and how to treat the stock at its current lows.
05:46
2 hours ago
Trending
- Citi’s Stuart Kaiser on why he is ‘cautiously siding with seasonal upside’ in the market
- Buyers pull the S&P 500 out of the hole
- OpenAI announces shopping research tool in latest e-commerce push
- A risky alpha bet in markets to revive AI trade
- Mizuho’s Jared Holz talks Novo Nordisk falling on Alzheimer’s trial
- Alphabet’s Gemini poses a serious threat to OpenAI’s ChatGPT, Jim Cramer says
- Blackrock’s iShares bitcoin fund sees record exodus as crypto heads for worst month since 2022
- AI, tech recovery, Nikkei 225, Hang Seng Index
Mizuho’s Jared Holz talks Novo Nordisk falling on Alzheimer’s trial
